Professor Enrique de Álava highlights the value of the PCC’s Pathway to Precision Cancer Care Strategic and Operational Guide

Comprehensive genomic profiling (CGP) is recognized as a critical component of precision oncology, helping to inform biomarker-guided treatment decisions and improve patient care. Many healthcare systems continue to face challenges when implementing CGP at scale.

In this video, Professor Enrique de Álava (Head of Pathology Service and Director of the Clinical Management Unit, UGC) shares his experience of integrating CGP into clinical practice and reflects on the opportunities and challenges associated with its wider adoption. Drawing on over a decade of experience using CGP, he discusses the operational, digital, and workforce considerations needed to support sustainable implementation.

The discussion explores key challenges, including fragmented genomic data infrastructure, the need for integrated testing pathways, workforce education, and the development of systems that enable the responsible use of genomic data to support both patient care and future research. These are all challenges addressed by the PCC’s Pathway to Precision Cancer Care: A Strategic and Operational Guide to Enhance Patient Access to CGP, designed to help stakeholders understand their current landscape, identify gaps and opportunities, and support wider adoption of CGP.

Explore the CGP Interactive Guide

The PCC’s CGP Interactive Guide has been developed to help stakeholders navigate the nine main challenges of CGP implementation. By providing a transparent view of current practice, highlighting implementation gaps, and showcasing opportunities for progress, the guide serves as a valuable resource to advance precision oncology.